Loading...
XIDX
BMHS
Market cap73mUSD
Nov 12, Last price  
155.00IDR
Name

Bundamedik Tbk PT

Chart & Performance

D1W1MN
XIDX:BMHS chart
P/E
107.38
P/S
0.83
EPS
1.44
Div Yield, %
0.36%
Shrs. gr., 5y
-2.67%
Rev. gr., 5y
7.05%
Revenues
1.61t
+3.84%
852,232,962,250964,892,513,4291,148,144,381,7121,710,759,215,7961,658,687,911,2221,488,197,483,3711,554,685,010,0001,614,340,772,000
Net income
12.42b
+3.98%
5,127,896,26931,316,953,346118,460,085,776315,363,896,754128,931,855,6627,461,134,36811,943,515,00012,418,961,000
CFO
250.62b
+637.57%
43,790,614,96189,715,033,956190,358,533,077349,438,392,180237,469,070,97451,438,728,48433,979,487,000250,621,860,000
Dividend
May 26, 20250.65 IDR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Operating as a key healthcare provider in Indonesia, PT Bundamedik Tbk (also known as PT Bunda Medik) had a significant footprint as of December 31, 2021. Its facilities included two maternal and child hospitals, three general hospitals, two clinics, ten specialized in-vitro fertilization (IVF) centers, and fourteen diagnostic laboratories. Beyond its direct medical services, the company diversified into the distribution of pharmaceuticals and medical equipment, alongside interests in the hotel industry, medical tourism, and management consulting. Established in 1973, PT Bundamedik Tbk is headquartered in Jakarta Pusat, Indonesia, and operates as a subsidiary of PT Bunda Investama Indonesia.
IPO date
Jul 06, 2021
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT